Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Threshold gets hypoxia PET imaging agent from Siemens Healthcare

Executive Summary

Threshold Pharmaceuticals Inc. (developing drugs that target tumor hypoxia) has acquired Siemens Healthcare’s radiolabeled hypoxia positron emission tomography (PET) tracer (18F)HF4 (flortanidazole (18F)), which it will use as a companion diagnostic for its cancer therapeutics in development.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Product Purchase

Related Companies